Viewing Study NCT00324727

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-07-04 @ 4:19 PM
Study NCT ID: NCT00324727
Status: COMPLETED
Last Update Posted: 2021-06-21
First Post: 2006-05-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Sponsor: Delcath Systems Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intraocular Melanoma View
None Melanoma (Skin) View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None liver metastases View
None extraocular extension melanoma View
None stage IV melanoma View
None recurrent melanoma View
None recurrent intraocular melanoma View
None metastatic intraocular melanoma View
None iris melanoma View
None ciliary body and choroid melanoma, medium/large size View